academic article

• Evaluating a household survey measure of psychic distress..  Psychological medicine.  13:607-622. 1983
• The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions..  Modern problems of pharmacopsychiatry.  7:79-110. 1974
• The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory..  Behavioral science.  19:1-15. 1974
• Predicting the relief of anxiety with meprobamate. An attempt at replication..  Archives of general psychiatry.  26:85-91. 1972
• Medication, anxiety reduction and patient report of significant life situation events..  Diseases of the nervous system.  32:240-244. 1971
• Validation of the MacAndrew-Rosen drug therapy scale..  Diseases of the nervous system.  31:680-683. 1970
• Is a double-blind clinical trial really double-blind? A report of doctors' medication guesses..  Psychopharmacologia.  16:329-336. 1970
• Medication attitudes and drug response..  Diseases of the nervous system.  30:453-459. 1969
• Dimensions of symptom distress in anxious neurotic outpatients..  Psychopharmacology bulletin.  5:19-32. 1969
• Predicting the relief of anxiety with meprobamate. Nondrug factors in the response of psychoneurotic outpatients..  Archives of general psychiatry.  19:619-630. 1968
• Some factors influencing the treatment expectations of anxious neurotic outpatients..  The Journal of nervous and mental disease.  145:208-220. 1967
• Side reactions on meprobamate and placebo..  Diseases of the nervous system.  28:39-45. 1967
• Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy..  Psychopharmacologia.  9:392-418. 1966
• Neurotics who fail to take their drugs..  The British journal of psychiatry : the journal of mental science.  111:1043-1049. 1965
• Dosage deviation and drug effects in drug trials..  The Journal of nervous and mental disease.  141:95-99. 1965
• Drug effects and initial severity of symptomatology..  Psychopharmacologia.  7:57-60. 1965